Radnostix, Inc. (INIS)
| Market Cap | 24.48M -36.5% |
| Revenue (ttm) | 11.23M -23.7% |
| Net Income | -2.86M |
| EPS | -0.01 |
| Shares Out | 529.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,120 |
| Open | 0.0400 |
| Previous Close | 0.0401 |
| Day's Range | 0.0400 - 0.0490 |
| 52-Week Range | 0.0302 - 0.1100 |
| Beta | 1.37 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Radnostix
Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, indu... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Radnostix and NANO Nuclear Energy Announce Joint Submission of Letter of Intent to NRC Seeking Consent for Transfer of License SUB-1011, Following Lea County Approval of Property LOI
IDAHO FALLS, Idaho, Oct. 19, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company") today announced that they have jointly submitted a...
Radnostix Signs Definitive Agreement to Divest DUF6 and Fluorine Assets to NANO Nuclear
BOISE, Idaho, Oct. 1, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ( "Radnostix" or the "Company") today announced that Radnostix and its wholly-owned subs...
Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition
IDAHO FALLS, Idaho, Aug. 13, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused technologi...
Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
IDAHO FALLS, Idaho, July 2, 2026 /PRNewswire/ -- Radnostix, Inc. (OTCQB: INIS) ("Radnostix" or the "Company"), a leader in radioisotope production and nuclear medicine solutions, today announced the s...
Radnostix, Inc. Reports FY2026 Q1 Results - Revenue Declines 27% Primarily Due to Voluntary Product Recalls, Isotope Supply Disruptions, and Planned Operational Shutdown
IDAHO FALLS, Idaho, May 21, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused products fo...
Radnostix, Inc. Reports FY2025 Results - Second-Highest Annual Revenue in Company History; Delivers Strong Growth in Calibration & Reference Products and Advances Key Product Launches in 2025
IDAHO FALLS, Idaho, April 1, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a leading manufacturer of radioisotope-focused te...
Radnostix announces mutual termination of APA related to DUF6 assets
Radnostix announced a mutual termination of an Asset Purchase Agreement dated February 8, 2024 entered into between RNX and its wholly owned subsidiary International Isotopes (INIS) Fluorine Products ...
International Isotopes announces name change to Radnostix
International Isotopes (INIS) has filed a Certificate of Amendment in the State of Texas to change its legal name to Radnostix. The company said, “Effective immediately, we will officially begin…
International Isotopes Inc. Announces Company Name Change to Radnostix, Inc.
IDAHO FALLS, Idaho, Dec. 31, 2025 /PRNewswire/ -- International Isotopes Inc. ("INIS" or the "Company") (OTCQB:INIS) today announced that it has filed a Certificate of Amendment in the State of Texas ...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025
IDAHO FALLS, Idaho , Nov. 14, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") is pleased to announce its financial results for the third quarter and nine month...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2025
Sale of product for the first six months of 2025 increased 13.5% or $820,529 Net Income (Loss) the first six months of 2025 improved 29% to a loss of $273,479 Non-GAAP EBITDA(1) the first six months ...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FIRST QUARTER 2025
Sale of product for first quarter increased 12% to $3.2 million. Nuclear Medicine Standards sale of product in the first quarter increased 73% to $1.3 million.
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2024
Revenues for fourth quarter increased 24% to $3.9 million. Full year revenues increased by 13% to $13.9 million, a historical high.
International Isotopes announces land acquisition, new facility lease agreement
International Isotopes (INIS) announced a strategic expansion of its company footprint with the recent purchase of vacant land adjacent to its current Idaho Falls facility. The Company has also entere...
International Isotopes, Inc. Expands Operational Footprint with Strategic Land Acquisition and Additional New Facility Lease Agreement
IDAHO FALLS, Idaho , Jan. 13, 2025 /PRNewswire/ -- International Isotopes, Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company"), is excited to announce a strategic expansion of its c...
International Isotopes, Inc. Announces the Amendment of the Acquisition of the AMICI, Inc. Product Line
IDAHO FALLS, Idaho , Jan. 9, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it has amended and finalized...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2024
Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the prior year Theranostics Sales increased 42% compared the Third Quarter in the prior year The Company report...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2024
Theranostics Sales increased 25% in the Second Quarter, and 16% for the Six Months Ended June 30, 2024 Gross Profit improved to 64%, a 7% increase, for the Six Months Ended June 30, 2024 Net Cash Prov...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE FIRST QUARTER OF 2024
Theranostics Products Revenues Increased 8% in the Three Months Ended March 31, 2024; Net Cash Provided By Operating Activities Was Approximately $400,000 in the Three Months Ended March 31, 2024; Gro...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR FISCAL YEAR 2023
Revenues Increased 10% in the Twelve Months Ended December 31, 2023 versus prior year Revenue of $12.3 million in the Twelve Months Ended December 31, 2023 was the highest in Company history Gross Pro...
INTERNATIONAL ISOTOPES TO DIVEST DEPLETED URANIUM DECONVERSION ASSETS TO AMERICAN FUEL RESOURCES FOR $12,500,000 CASH
IDAHO FALLS, Idaho , Feb. 8, 2024 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it has entered into a defini...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2023
Revenues Increased 14% in the Nine Months Ended September 30, 2023; Operating Loss Improved 43% in the Nine Months Ended September 30, 2023; and Gross Profit Increased 19% Nine Months Ended September ...
INTERNATIONAL ISOTOPES INC. ANNOUNCES FISCAL RESULTS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF 2023
Revenues Increased 28% in the Second Quarter; Net Cash Generation from Operations of more than $1,000,000 For The Six Months Ended June 30, 2023; June 30 th Cash Balance Remains In Excess Of $3,000,00...
INTERNATIONAL ISOTOPES INC. ANNOUNCES CHANGES IN EXECUTIVE OFFICERS AND DIRECTORS
Long Time Chief Executive Officer Steve Laflin Announced He Will Be Stepping Down September 1, 2023; Shahe Bagerdjian Appointed as CEO IDAHO FALLS, Idaho , July 18, 2023 /PRNewswire/ -- International ...
INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC.
The Products Include All Molds, Manufacturing, And Registration Rights To AMICI's Leading Products, Including The "Swirler", "UltraShield", and "Tru-Fit" Mouth Piece IDAHO FALLS, Idaho , June 21, 2023...